SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-09-097885
Filing Date
2009-05-04
Accepted
2009-05-04 15:55:45
Documents
5
Effectiveness Date
2009-05-04

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 20133
2 GRAPHIC g97808g24f01.jpg GRAPHIC 86894
3 GRAPHIC g97808g29m71.jpg GRAPHIC 158243
4 GRAPHIC g97808g41s33.jpg GRAPHIC 97871
5 GRAPHIC g97808g81j26.jpg GRAPHIC 169972
  Complete submission text file 0001193125-09-097885.txt   729107
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 09793390
SIC: 2835 In Vitro & In Vivo Diagnostic Substances